Development of a low-binding biochip demonstrates enhanced viability and metabolic functions in hepatic spheroids.
We developed a standardized 3D-printed low-binding biochip allowing both in situ formation and maintenance of hepatic spheroids. The spheroids displayed outstanding viability and metabolic competencies after 11 days of culture.
No takes yet. Share an insight, caveat, or question.
Martins et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: